How could artificial intelligence be used to help tailor treatments for juvenile idiopathic arthritis (JIA), a condition which affects 1 in 1,600 children and young people across the UK? Read insights from Dr Stephanie Shoop-Worrall and 13-year-old Trinity's story.
In her latest blog Professor Anne Barton, Director of Manchester BRC, shares what we are doing to advance discoveries that improve the health and wellbeing of children and young people.
In her latest blog Professor Anne Barton, Director of Manchester BRC, discusses our commitment to delivering on Research Inclusion and examples of this across our 4 Clusters.
Manchester researchers are part of an international team aiming to advance risk prediction, early detection of disease progression and personalised prevention in rheumatoid arthritis and inflammatory bowel disease to improve patient outcomes.
Recently the NIHR BRC and the NIHR North West Regional Research Delivery Network collaboratively hosted the Greater Manchester Inflammation Showcase: Musculoskeletal Diseases (MSK) and Dermatology Focus event at CityLabs 1.0.
Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug’s efficacy, according to the largest UK study of its kind.
For our PhDs in Focus blog series, Christina Diomatari outlines how their Manchester BRC PhD project aims to improve the safety of opioid use for patients with musculoskeletal conditions and those recovering from orthopaedic surgery, as part of the Rheumatic and Musculoskeletal Diseases theme.
For Arthritis Digest magazine, Louise Cook, Professor Will Dixon and Dr Meghna Jani explain how analysis of health data could help improve the lives and care of people living with arthritis.